vTv Therapeutics (VTVT) Net Margin (2016 - 2024)
Historic Net Margin for vTv Therapeutics (VTVT) over the last 10 years, with Q4 2024 value amounting to 21376.47%.
- vTv Therapeutics' Net Margin changed N/A to 21376.47% in Q4 2024 from the same period last year, while for Sep 2025 it was 138058.82%, marking a year-over-year decrease of 1362282200.0%. This contributed to the annual value of 1815.34% for FY2024, which is N/A changed from last year.
- Latest data reveals that vTv Therapeutics reported Net Margin of 21376.47% as of Q4 2024.
- In the past 5 years, vTv Therapeutics' Net Margin registered a high of 25.11% during Q4 2020, and its lowest value of 89562.5% during Q1 2020.
- Its 4-year average for Net Margin is 26450.67%, with a median of 14066.01% in 2021.
- Per our database at Business Quant, vTv Therapeutics' Net Margin crashed by -889237400bps in 2020 and then soared by 889604700bps in 2021.
- vTv Therapeutics' Net Margin (Quarter) stood at 25.11% in 2020, then tumbled by -312064bps to 78344.44% in 2021, then soared by 33bps to 52722.22% in 2022, then skyrocketed by 59bps to 21376.47% in 2024.
- Its Net Margin stands at 21376.47% for Q4 2024, versus 486.5% for Q1 2024 and 52722.22% for Q4 2022.